Efficacy and safety of edaravone sublingual tablet for patients with cerebral small vessel disease-related cognitive impairment: study protocol for a multicentre, randomised, double-blind, placebo-controlled trial
This trial will evaluate the efficacy and safety of EST in patients with CSVD-CI, potentially offering a new treatment strategy for this condition.
Authors
- X. Ronald Zhu (ORCID: https://orcid.org/0009-0003-4131-2916)
- Weidong Ling
- Lei Yu (ORCID: https://orcid.org/0000-0001-5659-7289)
- Lili Huang (ORCID: https://orcid.org/0000-0003-3251-6004)
- Yuting Mo (ORCID: https://orcid.org/0000-0003-4699-1244)
- Hailan Meng
- Rong Rong
- Qing Ye
- Yue Cheng
- Haifeng Chen
- Lai Qian
- Yun Xu
- Xin Zhang
Institutions
- Nanjing Brain Hospital (CN)
- Nanjing Drum Tower Hospital (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Stroke and Vascular Neurology
- Published
- 2026-03-11
- DOI
- https://doi.org/10.1136/svn-2025-004198
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China